Diebold Nixdorf, Incorporated
DBD
$75.36
-$2.12-2.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.32% | 1.46% | -2.86% | -3.75% | -2.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.32% | 1.46% | -2.86% | -3.75% | -2.66% |
| Cost of Revenue | 2.88% | -0.04% | -3.93% | -5.86% | -4.98% |
| Gross Profit | 8.56% | 5.88% | 0.43% | 3.04% | 4.91% |
| SG&A Expenses | 0.29% | 0.26% | 7.15% | 5.87% | -3.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 164.71% | -70.00% | -192.31% | 200.00% | -206.25% |
| Total Operating Expenses | 2.38% | -0.16% | -2.26% | -3.88% | -4.73% |
| Operating Income | 29.39% | 21.72% | -10.00% | -1.91% | 35.34% |
| Income Before Tax | 148.95% | 143.98% | 19.73% | -98.77% | -96.25% |
| Income Tax Expenses | -50.92% | -62.52% | -69.11% | -64.91% | 26.60% |
| Earnings from Continuing Operations | 1,480.00% | 771.72% | 2,565.00% | -100.47% | -100.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.64% | -40.00% | -50.00% | -75.00% | -46.67% |
| Net Income | 1,157.84% | 673.33% | 25,200.00% | -100.60% | -100.69% |
| EBIT | 29.39% | 21.72% | -10.00% | -1.91% | 35.34% |
| EBITDA | 15.78% | 11.70% | -7.75% | -3.56% | 19.24% |
| EPS Basic | 1,199.56% | 696.81% | 25,496.30% | -100.89% | -100.92% |
| Normalized Basic EPS | 78.44% | 48.01% | -14.66% | -0.49% | 285.40% |
| EPS Diluted | 1,167.62% | 682.40% | 124,100.00% | -100.91% | -100.95% |
| Normalized Diluted EPS | 76.26% | 46.36% | -15.28% | -0.65% | 284.19% |
| Average Basic Shares Outstanding | -3.86% | -2.19% | -1.00% | -11.64% | -29.11% |
| Average Diluted Shares Outstanding | -2.66% | -1.40% | -0.53% | -11.85% | -29.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |